WilmerHale has advised Gate Bioscience on the deal. Gate Bioscience, a biotechnology company focused on developing molecular gates—a new class of small molecule drugs aimed at...
WilmerHale has advised Gate Bioscience on the deal. Gate Bioscience, a biotechnology company focused on developing molecular gates—a new class of small molecule drugs aimed at...
